A month has gone by since the last earnings report for Colgate-Palmolive (CL). Shares have added about 0.4% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Colgate-Palmolive due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Colgate Q2 Earnings & Sales Miss Estimates, Decline Y/Y
Colgate reported dismal second-quarter 2019 results, wherein the top and bottom lines missed the Zacks Consensus Estimate. Both the metrics also dipped year over year. Unfavorable foreign currency mainly marred the company’s results.
Nevertheless, the company reiterated its guidance for 2019.
Adjusted earnings of 72 cents per share dropped 6% from the prior-year quarter and lagged the Zacks Consensus Estimate by a penny. Including one-time items, earnings were 68 cents per share compared with 73 cents in the year-ago period.
Total net sales of $3,866 million dipped 0.5% from the year-ago period and slightly missed the Zacks Consensus Estimate of $3,867 million. This year-over-year decline can be primarily attributed to negative currency impact of 4.5%.
However, this downside was somewhat offset by a 1% increase in global unit volume and a 3% rise in pricing.
On an organic basis, the company’s sales improved 4% driven by higher volumes and pricing. In fact, the company witnessed positive pricing in its all operating divisions.
Deeper Insight
An adjusted gross profit margin of 59.6% expanded 30 basis points (bps) from the prior-year quarter due to increased pricing and gains from cost savings under funding-the-growth program.
Growth was somewhat negated by escalated raw and packaging material expenses, including foreign currency transaction costs.
In the reported quarter, adjusted operating profit of $928 million fell 8%, while adjusted operating margin contracted 180 bps to 24%.
Operating margin was mainly impacted by a 200-bps increase in adjusted selling, general & administrative expenses, as a percentage of sales, partly offset by higher gross margin.
Year to date, Colgate’s market share of manual toothbrushes has reached 31.7%. Further, the company has continued with its leadership in the global toothpaste market, with 41.4% market share year to date.
Segmental Discussion
North America’s net sales (22% of total sales) improved 2.5%, reflecting a 2% rise in unit volume and a 1% increase in pricing, offset by currency headwinds of 0.5%. On an organic basis, sales improved 3%.
Latin America’s net sales (24% of total sales) slipped 0.5% year over year due to a negative currency impact of 7.5%. However, unit volume growth of 1.5% and price increases of 5.5% partly negated the decline in sales. During the quarter under review, volume benefited from gains in Mexico and Colombia, partly offset by a decline in Brazil. On an organic basis, sales were up 7%.
Europe’s net sales (15% of total sales) dropped 5% year over year due to 6% adverse impact of unfavorable currency exchange, somewhat offset by flat unit volume and a 1% rise in pricing. Volume benefited from gains in Spain and Greece, offset by decline in Germany and France. Further, organic sales in Europe inched up 1%.
The Asia Pacific’s net sales (17% of total sales) declined 4%, attributable to a 1.5% decline in unit volume and 3% impact of unfavorable currency exchange while pricing inched up 0.5%. Lower volume in Greater China was somewhat compensated with volume growth in Thailand. On an organic basis, sales for the Asia Pacific declined 1%.
Africa/Eurasia’s net sales (6% of total sales) edged up 0.5% year over year owing to a 3.5% rise in unit volume and a 6% increase in pricing, offset by currency headwinds of 9%. During the quarter, volume gains in Russia and the Gulf States were partly negated by declines in Saudi Arabia and South Africa. Organic sales for Africa/Eurasia improved 9.5%.
Hill’s Pet Nutrition’s net sales (16% of total sales) rose 3.5% from the year-ago quarter. Results gained from a 2% increase in unit volume and a 4% rise in pricing, offset by a 2.5% negative impact of currency. Volume growth in the United States, South Africa and Western Europe were partly negated by soft volumes in Japan. On an organic basis, sales rose 6%.
Other Financial Details
Colgate ended second-quarter 2019 with cash and cash equivalents of $863 million, and total debt of $6,645 million. Net cash provided by operating activities amounted to $1,249 million as of Jun 30, 2019.
Outlook
Going into 2019, the company expects top-line gains backed by accelerated investments in its brands, higher pricing and strong innovation.
Further, the company is on track to expand its premium skin care portfolio with the agreement to buy the Filorga skin care business. This impact is not included in the guidance.
Driven by these efforts, the company reiterated sales and earnings view for 2019. It expects sales to be between flat and up low-single digit on current spot rates.
Moreover, it estimates organic sales growth of 2-4% for the current year. Management expects top-line results to come toward the higher end of its guided range.
Moreover, the company expects gross margin expansion in 2019, both on a GAAP and adjusted basis. On a GAAP basis, earnings per share for 2019 are likely to decline in a low-single-digit.
Meanwhile, adjusted earnings per share are expected to decline in a mid-single-digit.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in fresh estimates.
VGM Scores
Currently, Colgate-Palmolive has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. Following the exact same course, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been trending upward for the stock, and the magnitude of these revisions has been net zero. It comes with little surprise Colgate-Palmolive has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Colgate-Palmolive Company (NYSE:CL): Free Stock Analysis Report
Original post